Verity Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,614
Closed -$213K 200
2021
Q2
$213K Buy
+1,614
New +$211K 0.12% 209
2015
Q4
Sell
-6,385
Closed -$392K 78
2015
Q3
$392K Buy
+6,385
New +$446K 0.39% 48
2015
Q2
Sell
-3,407
Closed -$262K 94
2015
Q1
$262K Sell
3,407
-11,221
-77% -$804K 0.25% 52
2014
Q4
$980K Buy
+14,628
New +$923K 0.95% 28

Other funds holding DGX

Verity Asset Management's DGX Position: Q3 2021 in Review

Verity Asset Management sold out of Quest Diagnostics (DGX) in Q3 2021, closing a stake of 1,614 shares — an estimated $213K sold.

Verity Asset Management first reported a position in DGX in Q4 2014 and held it in 4 quarters. The position peaked at $980K in Q4 2014. 838 funds tracked by Wall St. Rank hold DGX as of Q3 2021.

  • Verity Asset Management reported no remaining Quest Diagnostics position as of Q3 2021 after selling out during the quarter.
  • Verity Asset Management sold 1,614 Quest Diagnostics shares in Q3 2021, an estimated $213K.
  • Verity Asset Management first reported a position in Quest Diagnostics in Q4 2014 and held it in 4 quarters.
  • Verity Asset Management's Quest Diagnostics position peaked at $980K in Q4 2014.
  • 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.

Based on Verity Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.